Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
2
×
new york top stories
san francisco blog main
san francisco top stories
startups
vc
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
azacitidine
beta-thalassemia
bioeurope
biogen
biomarin pharmaceutical
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
dacogen
deals
decitabine
deerfield management
detroit blog main
detroit top stories
dna
drug development
drug discovery
epigenetics
epizyme
What
developing
2
×
medicines
2
×
new
activity
aims
approach
approvals
based
bio
biogen
biotech
called
clamped
covid
debuts
delays
drugs
economic
epigenetic
epigenetics
fast
fda
field
flagship’s
including
ipo
isn’t
lot
morning
omega
oric’s
research
roundup
showing
spread
startup
step
testing
therapeutics
touting
Language
unset
Current search:
developing
×
medicines
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
